Stock JUBLPHARMA JUBILANT PHARMOVA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jubilant Pharmova Limited

Equities

JUBLPHARMA

INE700A01033

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 02:02:50 2024-04-29 am EDT 		5-day change 1st Jan Change
684.8 INR +0.59% Intraday chart for Jubilant Pharmova Limited +0.52% +25.47%
Apr. 25 Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA MT
Apr. 17 Jubilant Pharmova Unit Gets VAI Status for Roorkee, India Facility MT

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 130,784 103,465 39,635 108,375 61,740 44,418
Enterprise Value (EV) 1 162,769 138,045 73,537 129,776 83,768 70,861
P/E ratio 20.4 x 18 x 4.41 x 13 x 14.9 x -72.8 x
Yield 0.36% 0.68% 2.01% 0.73% 1.29% 1.79%
Capitalization / Revenue 1.74 x 1.14 x 0.43 x 1.78 x 1.01 x 0.71 x
EV / Revenue 2.17 x 1.52 x 0.8 x 2.13 x 1.37 x 1.13 x
EV / EBITDA 11.2 x 8.29 x 4.1 x 8.84 x 7.86 x 11 x
EV / FCF 38.8 x 193 x 17.8 x 12.3 x 181 x -50.8 x
FCF Yield 2.58% 0.52% 5.61% 8.11% 0.55% -1.97%
Price to Book 3.2 x 2.2 x 0.71 x 2.28 x 1.16 x 0.82 x
Nbr of stocks (in thousands) 155,732 155,774 159,272 159,281 159,206 159,174
Reference price 2 839.8 664.2 248.8 680.4 387.8 279.0
Announcement Date 8/31/18 8/31/19 8/19/20 8/30/21 9/3/22 8/8/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net sales 1 75,178 91,108 91,544 60,985 61,302 62,817
EBITDA 1 14,477 16,643 17,944 14,676 10,663 6,462
EBIT 1 11,985 13,926 15,183 11,443 8,398 3,749
Operating Margin 15.94% 15.29% 16.59% 18.76% 13.7% 5.97%
Earnings before Tax (EBT) 1 8,591 9,038 12,105 8,711 6,304 277.8
Net income 1 6,428 5,745 8,982 8,359 4,139 -609.8
Net margin 8.55% 6.31% 9.81% 13.71% 6.75% -0.97%
EPS 2 41.25 36.86 56.39 52.48 26.00 -3.832
Free Cash Flow 1 4,196 715.8 4,124 10,523 463.4 -1,396
FCF margin 5.58% 0.79% 4.5% 17.25% 0.76% -2.22%
FCF Conversion (EBITDA) 28.98% 4.3% 22.98% 71.7% 4.35% -
FCF Conversion (Net income) 65.28% 12.46% 45.91% 125.89% 11.19% -
Dividend per Share 2 3.000 4.500 5.000 5.000 5.000 5.000
Announcement Date 8/31/18 8/31/19 8/19/20 8/30/21 9/3/22 8/8/23
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 26,643 19,734 16,346 16,574 13,105 15,275 14,517 15,995 15,525
EBITDA 1 4,928 3,746 3,880 3,395 1,942 2,474 1,924 2,188 1,459
EBIT 1 3,968 2,884 2,872 2,397 1,009 1,468 977.3 1,248 516
Operating Margin 14.89% 14.61% 17.57% 14.46% 7.7% 9.61% 6.73% 7.8% 3.32%
Earnings before Tax (EBT) 1 3,432 3,236 2,465 2,080 702 1,043 692.1 390.6 103.8
Net income 1 3,099 2,139 1,605 1,426 509.9 595.5 470.4 54.9 -156.7
Net margin 11.63% 10.84% 9.82% 8.61% 3.89% 3.9% 3.24% 0.34% -1.01%
EPS 19.46 - 10.09 8.970 - 3.740 - 0.3400 -
Dividend per Share - - - - - - - - -
Announcement Date 2/5/21 6/4/21 7/23/21 10/22/21 2/4/22 5/27/22 8/2/22 10/21/22 2/3/23
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 31,985 34,580 33,902 21,401 22,028 26,443
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.209 x 2.078 x 1.889 x 1.458 x 2.066 x 4.092 x
Free Cash Flow 1 4,196 716 4,124 10,523 463 -1,396
ROE (net income / shareholders' equity) 17.1% 13% 17.3% 11.1% 8.21% -1.21%
ROA (Net income/ Total Assets) 8.03% 8.26% 7.91% 6.67% 5.55% 2.22%
Assets 1 80,061 69,583 113,544 125,293 74,559 -27,521
Book Value Per Share 2 262.0 302.0 352.0 298.0 334.0 339.0
Cash Flow per Share 2 15.70 63.10 77.30 31.50 61.80 63.70
Capex 1 4,891 6,559 5,742 5,275 6,000 8,144
Capex / Sales 6.51% 7.2% 6.27% 8.65% 9.79% 12.97%
Announcement Date 8/31/18 8/31/19 8/19/20 8/30/21 9/3/22 8/8/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JUBILANT PHARMOVA LIMITED Stock Jubilant Pharmova Limited
+25.47% 1.3B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. JUBLPHARMA Stock
  4. Financials Jubilant Pharmova Limited